Skip to main content
SpringerLink
Log in

Potentially addictive barbiturates or opioid analgesics are used by a large proportion of patients with migraine,

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. The National Headache Foundation.Survey: Migraine Patients Taking Potentially Addictive Barbiturate or Opioid Medications Not Approved by FDA as Migraine Treatments. Media Release: 16 May 2007. Available from: URL: http://www.headaches.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Potentially addictive barbiturates or opioid analgesics are used by a large proportion of patients with migraine,. Pharmacoecon. Outcomes News 529, 10 (2007). https://doi.org/10.2165/00151234-200705290-00028

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705290-00028

Keywords

Search

Navigation